drugset / Trial / NCT00208130

Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians

NCT00208130

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to investigate the safety and efficacy of topiramate in the treatment of PTSD in women survivors of domestic violence and/or rape trauma as measured by the Clinician-Administered PTSD Scale (CAPS) for DSM-IV.

Timeline

Start
2001-10
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 100 mg